Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP)
|
23.13 -0.24 (-1.03%) 3:01EST Delayed |
|
|
|
- Compare ENDP with:
- View: Line | Candlestick
Company Profile
Endo Pharmaceuticals Holdings Inc.
100 Endo Boulevard
Chadds Ford, PA 19317
United States - Map
Phone: (610) 558-9800
Fax: (610) 558-8979
Website: www.endo.com
State of incorporation: Delaware
CEO: David P. Holveck
Employees: 1,487
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A specialty pharmaceutical company
A specialty pharmaceutical company, which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain.
Recent news for ENDP
-
Endo Pharmaceuticals to Announce Second Quarter 2010 Financial Results on July 30, 2010
PR Newswire - Jul 20 at 4:30PM (EST)
-
Endo Pharmaceuticals Recognizes 10 Years as a Public Company by Ringing the NASDAQ Opening Bell
PR Newswire - Jul 19 at 7:30AM (EST)
-
GlobeNewswire - Jul 16 at 11:00AM (EST)
-
Endo completes $223M HealthTronics acquisition
AP - Jul 15 at 1:07PM (EST)
-
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
PR Newswire - Jul 15 at 8:30AM (EST)
-
4 Reasonable Value Stocks Starting to Break Out
Seeking Alpha - Jul 12 at 4:58PM (EST)
-
Briefing.com - Jul 12 at 8:32AM (EST)
-
PR Newswire - Jul 12 at 8:30AM (EST)
-
Wall Street Transcript - Jul 07 at 1:58PM (EST)
-
8 Healthcare Sector Takeover Targets
Seeking Alpha - Jul 06 at 5:01AM (EST)
Member sentiment (?) Neutral
Recent opinions on ENDP
-
Company Updates: PPCO, RNN, CRY, ABII, AEZS, DSCO, GTXI, VVUS
Jun 08 at 10:00PM (EST) (By StocksHaven)
Top members owning ENDP
-
Top 52%
+0.20%
-
Top 41%
+0.70%
-
Top 24%
+1.47%
* Average monthly return vs. S&P 500